Works matching AU Christophe, Borg


Results: 93
    1

    EMT is associated with an epigenetic signature of ECM remodeling genes.

    Published in:
    Cell Death & Disease, 2019, v. 10, n. 3, p. 1, doi. 10.1038/s41419-019-1397-4
    By:
    • Peixoto, Paul;
    • Etcheverry, Amandine;
    • Aubry, Marc;
    • Missey, Anaïs;
    • Lachat, Camille;
    • Perrard, Jérôme;
    • Hendrick, Elodie;
    • Delage-Mourroux, Régis;
    • Mosser, Jean;
    • Borg, Christophe;
    • Feugeas, Jean-Paul;
    • Herfs, Michaël;
    • Boyer-Guittaut, Michaël;
    • Hervouet, Eric
    Publication type:
    Article
    2
    3

    Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-01962-6
    By:
    • Lopez, Morgane;
    • Spehner, Laurie;
    • André, Fabrice;
    • Viot, Julien;
    • Seffar, Evan;
    • Marguier, Amélie;
    • Curtit, Elsa;
    • Meynard, Guillaume;
    • Dobi, Erion;
    • Ladoire, Sylvain;
    • Boidot, Romain;
    • Loyon, Romain;
    • Derangere, Valentin;
    • Bidard, François-Clément;
    • Borg, Christophe;
    • Mansi, Laura;
    • Kroemer, Marie
    Publication type:
    Article
    4
    5
    6
    7
    8

    Nanovectorization of DNA Through Cells Using Protamine Complexation.

    Published in:
    2016
    By:
    • Boukari, Khaoula;
    • Caoduro, Cécile;
    • Kacem, Raoudha;
    • Skandrani, Nadia;
    • Borg, Christophe;
    • Boulahdour, Hatem;
    • Gharbi, Tijani;
    • Delage-Mourroux, Régis;
    • Hervouet, Eric;
    • Pudlo, Marc;
    • Picaud, Fabien;
    • Caoduro, Cécile;
    • Delage-Mourroux, Régis
    Publication type:
    journal article
    9
    10

    Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 9, p. 2357, doi. 10.1007/s00432-019-02970-8
    By:
    • Ghiringhelli, Francois;
    • Vincent, Julie;
    • Bengrine, Leila;
    • Borg, Christophe;
    • Jouve, Jean Louis;
    • Loffroy, Romaric;
    • Guiu, Boris;
    • Blanc, Julie;
    • Bertaut, Aurélie
    Publication type:
    Article
    11

    Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.

    Published in:
    Gastric Cancer, 2019, v. 22, n. 4, p. 828, doi. 10.1007/s10120-018-00909-5
    By:
    • Bang, Yung-Jue;
    • Kang, Yoon-Koo;
    • Catenacci, Daniel V.;
    • Muro, Kei;
    • Fuchs, Charles S.;
    • Geva, Ravit;
    • Hara, Hiroki;
    • Golan, Talia;
    • Garrido, Marcelo;
    • Jalal, Shadia I.;
    • Borg, Christophe;
    • Doi, Toshihiko;
    • Yoon, Harry H.;
    • Savage, Mary J.;
    • Wang, Jiangdian;
    • Dalal, Rita P.;
    • Shah, Sukrut;
    • Wainberg, Zev A.;
    • Chung, Hyun Cheol
    Publication type:
    Article
    12
    13

    Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07593-7
    By:
    • Selmani, Zohair;
    • Molimard, Chloé;
    • Overs, Alexis;
    • Bazan, Fernando;
    • Chaigneau, Loic;
    • Dobi, Erion;
    • Meneveau, Nathalie;
    • Mansi, Laura;
    • Paillard, Marie-Justine;
    • Meynard, Guillaume;
    • Viot, Julien;
    • Algros, Marie-Paule;
    • Borg, Christophe;
    • Feugeas, Jean-Paul;
    • Pivot, Xavier;
    • Prétet, Jean-Luc;
    • Curtit, Elsa
    Publication type:
    Article
    14

    ATG9A Is Overexpressed in Triple Negative Breast Cancer and Its In Vitro Extinction Leads to the Inhibition of Pro-Cancer Phenotypes.

    Published in:
    Cells (2073-4409), 2018, v. 7, n. 12, p. 248, doi. 10.3390/cells7120248
    By:
    • Claude-Taupin, Aurore;
    • Fonderflick, Leïla;
    • Gauthier, Thierry;
    • Mansi, Laura;
    • Pallandre, Jean-René;
    • Borg, Christophe;
    • Perez, Valérie;
    • Monnien, Franck;
    • Algros, Marie-Paule;
    • Vigneron, Marc;
    • Adami, Pascale;
    • Delage-Mourroux, Régis;
    • Peixoto, Paul;
    • Herfs, Michael;
    • Boyer-Guittaut, Michaël;
    • Hervouet, Eric
    Publication type:
    Article
    15
    16
    17

    QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells.

    Published in:
    PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086641
    By:
    • Poillet, Laura;
    • Pernodet, Nicolas;
    • Boyer-Guittaut, Michaël;
    • Adami, Pascale;
    • Borg, Christophe;
    • Jouvenot, Michèle;
    • Delage-Mourroux, Régis;
    • Despouy, Gilles
    Publication type:
    Article
    18
    19
    20

    Additive value of pre-operative and one-month post-operative lymphocyte count for death-risk stratification in patients with resectable pancreatic cancer: a multicentric study.

    Published in:
    BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2860-6
    By:
    • d'Engremont, Christelle;
    • Vernerey, Dewi;
    • Pointet, Anne-Laure;
    • Simone, Gaël;
    • Fein, Francine;
    • Heyd, Bruno;
    • Koch, Stéphane;
    • Vuitton, Lucine;
    • Kim, Stefano;
    • Jary, Marine;
    • Lamfichek, Najib;
    • Turco, Celia;
    • Lakkis, Zaher;
    • Berger, Anne;
    • Bonnetain, Franck;
    • Taieb, Julien;
    • Bachellier, Philippe;
    • Borg, Christophe
    Publication type:
    Article
    21
    22
    23
    24
    25

    A new anti-mesothelin antibody targets selectively the membrane-associated form.

    Published in:
    mAbs (1942-0862), 2017, v. 9, n. 3, p. 567, doi. 10.1080/19420862.2017.1288770
    By:
    • Asgarov, Kamal;
    • Balland, Jeremy;
    • Tirole, Charline;
    • Bouard, Adeline;
    • Mougey, Virginie;
    • Ramos, Diana;
    • Barroso, António;
    • Zangiacomi, Vincent;
    • Jary, Marine;
    • Kim, Stefano;
    • Gonzalez-Pajuelo, Maria;
    • Royer, Bernard;
    • de Haard, Hans;
    • Clark, Andy;
    • Wijdenes, John;
    • Borg, Christophe
    Publication type:
    Article
    26

    DNA damage response defect in Williams-Beuren syndrome.

    Published in:
    International Journal of Molecular Medicine, 2017, v. 39, n. 3, p. 622, doi. 10.3892/ijmm.2017.2861
    By:
    • GUENAT, DAVID;
    • MERLA, GIUSEPPE;
    • DECONINCK, ERIC;
    • BORG, CHRISTOPHE;
    • ROHRLICH, PIERRE-SIMON
    Publication type:
    Article
    27
    28

    Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.

    Published in:
    2010
    By:
    • Chalmin, Fanny;
    • Ladoire, Sylvain;
    • Mignot, Grégoire;
    • Vincent, Julie;
    • Bruchard, Mélanie;
    • Remy-Martin, Jean-Paul;
    • Boireau, Wilfrid;
    • Rouleau, Alain;
    • Simon, Benoit;
    • Lanneau, David;
    • De Thonel, Aurélie;
    • Multhoff, Gabriele;
    • Hamman, Arlette;
    • Martin, François;
    • Chauffert, Bruno;
    • Solary, Eric;
    • Zitvogel, Laurence;
    • Garrido, Carmen;
    • Ryffel, Bernhard;
    • Borg, Christophe
    Publication type:
    journal article
    29

    Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell --dependent antitumor effects.

    Published in:
    Journal of Clinical Investigation, 2004, v. 114, n. 3, p. 379, doi. 10.1172/JCI200421102
    By:
    • Borg, Christophe;
    • Terme, Magali;
    • Taieb, Julien;
    • Ménard, Cedric;
    • Flament, Caroline;
    • Robert, Caroline;
    • Maruyama, Koji;
    • Wakasugi, Hiro;
    • Angevin, Eric;
    • Thielemans, Kris;
    • Cesne, Axel Le;
    • Chung-Scott, Véronique;
    • Lazar, Vladimir;
    • Tchou, Isabelle;
    • Crépineau, Florent;
    • Lemoine, François;
    • Bernard, Jacky;
    • Fletcher, Jonhantan A.;
    • Turhan, Ali;
    • Biay, Jean-Yves
    Publication type:
    Article
    30

    Phase II multicentre study of efficacy and feasibility of dose-intensified preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) in resectable gastroesophageal cancer.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 1, p. 141, doi. 10.1007/s00280-014-2482-0
    By:
    • Jary, Marine;
    • Ghiringhelli, Francois;
    • Jacquin, Marion;
    • Fein, Francine;
    • Nguyen, Thierry;
    • Cleau, Denis;
    • Nerich, Virginie;
    • El Gani, Maryame;
    • Mathieu, Pierre;
    • Valmary-Degano, Séverine;
    • Arnould, Laurent;
    • Lassabe, Catherine;
    • Lamfichekh, Najib;
    • Fratté, Serge;
    • Paget-Bailly, Sophie;
    • Bonnetain, Franck;
    • Borg, Christophe;
    • Kim, Stefano
    Publication type:
    Article
    31

    Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 10, p. 2325, doi. 10.1002/ijc.30367
    By:
    • Jary, Marine;
    • Lecomte, Thierry;
    • Bouché, Olivier;
    • Kim, Stefano;
    • Dobi, Erion;
    • Queiroz, Lise;
    • Ghiringhelli, Francois;
    • Etienne, Hélène;
    • Léger, Julie;
    • Godet, Yann;
    • Balland, Jérémy;
    • Lakkis, Zaher;
    • Adotevi, Olivier;
    • Bonnetain, Franck;
    • Borg, Christophe;
    • Vernerey, Dewi
    Publication type:
    Article
    32

    CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.

    Published in:
    International Journal of Cancer, 2015, v. 137, n. 1, p. 116, doi. 10.1002/ijc.29366
    By:
    • Vauchy, Charline;
    • Gamonet, Clementine;
    • Ferrand, Christophe;
    • Daguindau, Etienne;
    • Galaine, Jeanne;
    • Beziaud, Laurent;
    • Chauchet, Adrien;
    • Henry Dunand, Carole J.;
    • Deschamps, Marina;
    • Rohrlich, Pierre Simon;
    • Borg, Christophe;
    • Adotevi, Olivier;
    • Godet, Yann
    Publication type:
    Article
    33
    34

    Biomarqueurs actuels et à venir dans les cancers œsogastriques.

    Published in:
    Hépato-Gastro & Oncologie Digestive, 2023, v. 30, p. 7, doi. 10.1684/hpg.2023.2630
    By:
    • Bibeau, Frédéric;
    • Monnien, Franck;
    • Laydi, Maxime;
    • Mathieu, Pierre;
    • Viennot, Angélique;
    • Viot, Julien;
    • Borg, Christophe;
    • Overs, Alexis;
    • Molimard, Chloé
    Publication type:
    Article
    35

    Prise en charge du carcinome épidermoïde avancé du canal anal.

    Published in:
    Hépato-Gastro & Oncologie Digestive, 2020, v. 27, n. 9, p. 873, doi. 10.1684/hpg.2020.2025
    By:
    • Stouvenot, Morgane;
    • Vuitton, Lucine;
    • Meurisse, Aurélia;
    • Spehner, Laurie;
    • Jacquin, Marion;
    • Fein, Francine;
    • Klajer, Élodie;
    • Vienot, Angélique;
    • Boulbair, Fatiha;
    • Pernot, Mandy;
    • Jary, Marine;
    • Borg, Christophe;
    • Kim, Stefano
    Publication type:
    Article
    36

    Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.

    Published in:
    Journal of Translational Medicine, 2005, v. 3, p. 10, doi. 10.1186/1479-5876-3-10
    By:
    • Escudier, Bernard;
    • Dorval, Thierry;
    • Chaput, Nathalie;
    • André, Fabrice;
    • Caby, Marie-Pierre;
    • Novault, Sophie;
    • Flament, Caroline;
    • Leboulaire, Christophe;
    • Borg, Christophe;
    • Amigorena, Sebastian;
    • Boccaccio, Catherine;
    • Bonnerot, Christian;
    • Dhellin, Olivier;
    • Movassagh, Mojgan;
    • Piperno, Sophie;
    • Robert, Caroline;
    • Serra, Vincent;
    • Valente, Nancy;
    • Le Pecq, Jean-Bernard;
    • Spatz, Alain
    Publication type:
    Article
    37

    Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2.

    Published in:
    Liver International, 2020, v. 40, n. 8, p. 2008, doi. 10.1111/liv.14462
    By:
    • Kudo, Masatoshi;
    • Galle, Peter R.;
    • Llovet, Josep M.;
    • Finn, Richard S.;
    • Vogel, Arndt;
    • Motomura, Kenta;
    • Assenat, Eric;
    • Merle, Philippe;
    • Brandi, Giovanni;
    • Daniele, Bruno;
    • Okusaka, Takuji;
    • Tomášek, Jiří;
    • Borg, Christophe;
    • Dadduzio, Vincenzo;
    • Morimoto, Manabu;
    • Pracht, Marc;
    • Jen, Min‐Hua;
    • Drove Ubreva, Nora;
    • Widau, Ryan C.;
    • Shinozaki, Kenta
    Publication type:
    Article
    38

    The NHance ® Mutation-Equipped Anti-MET Antibody ARGX-111 Displays Increased Tissue Penetration and Anti-Tumor Activity in Advanced Cancer Patients.

    Published in:
    Biomedicines, 2021, v. 9, n. 6, p. 665, doi. 10.3390/biomedicines9060665
    By:
    • Aftimos, Philippe;
    • Rolfo, Christian;
    • Rottey, Sylvie;
    • Barthélémy, Philippe;
    • Borg, Christophe;
    • Park, Keunchil;
    • Oh, Do-Youn;
    • Kim, Sang-We;
    • De Jonge, Natalie;
    • Hanssens, Valérie;
    • Zwanenpoel, Karen;
    • Molthoff, Carla;
    • Vugts, Daniëlle;
    • Dreier, Torsten;
    • Verheesen, Peter;
    • van Dongen, Guus A.M.S.;
    • Jacobs, Julie;
    • Van Rompaey, Luc;
    • Hultberg, Anna;
    • Michieli, Paolo
    Publication type:
    Article
    39

    Feasibility of health-related quality of life (HRQoL) assessment for cancer patients using electronic patient-reported outcome (ePRO) in daily clinical practice.

    Published in:
    Quality of Life Research, 2021, v. 30, n. 11, p. 3255, doi. 10.1007/s11136-020-02721-0
    By:
    • Mouillet, Guillaume;
    • Falcoz, Antoine;
    • Fritzsch, Joëlle;
    • Almotlak, Hamadi;
    • Jacoulet, Pascale;
    • Pivot, Xavier;
    • Villanueva, Cristian;
    • Mansi, Laura;
    • Kim, Stefano;
    • Curtit, Elsa;
    • Meneveau, Nathalie;
    • Adotevi, Olivier;
    • Jary, Marine;
    • Eberst, Guillaume;
    • Vienot, Angelique;
    • Calcagno, Fabien;
    • Pozet, Astrid;
    • Djoumakh, Oumelkheir;
    • Borg, Christophe;
    • Westeel, Virginie
    Publication type:
    Article
    40

    Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?

    Published in:
    Quality of Life Research, 2015, v. 24, n. 1, p. 5, doi. 10.1007/s11136-013-0583-6
    By:
    • Anota, Amélie;
    • Hamidou, Zeinab;
    • Paget-Bailly, Sophie;
    • Chibaudel, Benoist;
    • Bascoul-Mollevi, Caroline;
    • Auquier, Pascal;
    • Westeel, Virginie;
    • Fiteni, Frederic;
    • Borg, Christophe;
    • Bonnetain, Franck
    Publication type:
    Article
    41

    PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22764-2
    By:
    • Ercolano, Giuseppe;
    • Gomez-Cadena, Alejandra;
    • Dumauthioz, Nina;
    • Vanoni, Giulia;
    • Kreutzfeldt, Mario;
    • Wyss, Tania;
    • Michalik, Liliane;
    • Loyon, Romain;
    • Ianaro, Angela;
    • Ho, Ping-Chih;
    • Borg, Christophe;
    • Kopf, Manfred;
    • Merkler, Doron;
    • Krebs, Philippe;
    • Romero, Pedro;
    • Trabanelli, Sara;
    • Jandus, Camilla
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50